Ambrx Biopharma, Inc.

Paradigm Biocapital Advisors LP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

4,352,689

Value ($000)

61,982

Weight

2.9%

2023 Q4 - 2023 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	61,982	2.9%	4,352,689	12/31/2023